miR‐181a/b therapy in lung cancer: reality or myth?-Reference-Cited by-同舟云学术

miR‐181a/b therapy in lung cancer: reality or myth?

Published:2019-01 Issue:1 Volume:13 Page:9-25
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Braicu Cornelia¹,Gulei Diana²,Cojocneanu Roxana¹,Raduly Lajos¹,Jurj Ancuta¹,Knutsen Erik³,Calin George Adrian³⁴,Berindan‐Neagoe Ioana¹²⁵

Affiliation:

1. Research Center for Functional Genomics, Biomedicine and Translational Medicine ‘Iuliu Hatieganu’ University of Medicine and Pharmacy Cluj‐Napoca Romania

2. MedFuture Research Center for Advanced Medicine ‘Iuliu Hatieganu’ University of Medicine and Pharmacy Cluj‐Napoca Romania

3. Department of Experimental Therapeutics The University of Texas MD Anderson Cancer Center Houston TX USA

4. Center for RNA Inference and Non‐Coding RNA The University of Texas MD Anderson Cancer Center Houston TX USA

5. Department of Functional Genomics and Experimental Pathology The Oncology Institute ‘Prof. Dr. Ion Chiricuta’ Cluj‐Napoca Romania

Funder

National Institutes of Health

National Cancer Institute

National Institute of General Medical Sciences

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12420

Reference125 articles.

1. Immune checkpoint inhibitors for advanced non-small cell lung cancer: emerging sequencing for new treatment targets

2. MiR-181b Antagonizes Atherosclerotic Plaque Vulnerability Through Modulating Macrophage Polarization by Directly Targeting Notch1

3. Nanoparticles in the clinic

4. Epigenetic silencing of miR-181c by DNA methylation in glioblastoma cell lines

5. Noncoding RNAs in Lung Cancer Angiogenesis

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysregulated MicroRNAs in Chronic Lymphocytic Leukemia;Cureus;2024-09-06

2. Acovenoside A as a novel therapeutic approach to boost taxol and carboplatin apoptotic and antiproliferative activities in NSCLC: Interplay of miR-630/miR-181a and apoptosis genes;Bioorganic Chemistry;2023-10

3. MicroRNA-181a-5p alleviates acute liver failure in mice by inhibiting HMGB1;Cellular and Molecular Biology;2023-09-30

4. Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC;BMC Cancer;2023-09-12

5. Artificial miRNAs derived from miR‐181 family members have potential in cancer therapy due to an altered spectrum of target mRNAs;FEBS Letters;2023-07-09